Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Signal Transduction R-HSA-162582,25/2465,7.576998134316742e-10,4.1446179794712585e-7,0,0,6.184991520633126,129.88936068554543,CHRM1;CHRM4;CHRM5;FOXO3;CENPA;RAP1B;PPP2CB;H3C13;PRKACG;RPS6KA1;ERBB2;CAMK2G;EIF4E;FGA;MAP2K1;ANXA1;BAD;H2BC3;CDC25C;ESR1;MTOR;NR4A1;CDK1;PDE5A;TP53
Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,5/25,6.050510141597554e-9,1.2458272941728474e-6,0,0,101.66326530612244,1923.7864991344268,PPP2CB;CDK7;CDK1;CDC25C;CDC25A
Intracellular Signaling By Second Messengers R-HSA-9006925,10/306,8.010454129783855e-9,1.2458272941728474e-6,0,0,15.087530712530713,281.2695686491459,PPP2CB;NR4A1;BAD;PRKACG;ERBB2;FOXO3;TP53;CAMK2G;ESR1;MTOR
Disease R-HSA-1643685,20/1736,9.493846198687724e-9,1.2458272941728474e-6,0,0,6.249143013848896,115.4380568237058,RB1;FGA;MAP2K1;BAD;H2BC3;CDC25C;FOXO3;ESR1;CDC25A;MTOR;GYS2;RAP1B;PPP2CB;NR4A1;CDK7;H3C13;PRKACG;ERBB2;TP53;CAMK2G
"Cell Cycle, Mitotic R-HSA-69278",12/523,1.1387818045455642e-8,1.2458272941728474e-6,0,0,10.866648029074645,198.75883431835933,RB1;RBL2;PPP2CB;CDK7;H3C13;H2BC3;CDK1;NEK2;CDC25C;TP53;CENPA;CDC25A
Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,11/424,1.4409816937372564e-8,1.3136949774571324e-6,0,0,12.098823131933104,218.44856041153287,RAP1B;FGA;PPP2CB;NR4A1;MAP2K1;BAD;ERBB2;FOXO3;CAMK2G;ESR1;MTOR
Diseases Of Programmed Cell Death R-HSA-9645723,6/71,3.642040820001883e-8,2.8459947550586143e-6,0,0,38.23269230769231,654.8547746954646,H3C13;H2BC3;CDC25C;FOXO3;TP53;CDC25A
Cell Cycle R-HSA-1640170,12/654,1.3178063813031577e-7,8.58017894079792e-6,0,0,8.59101023587005,136.0998763238915,RB1;RBL2;PPP2CB;CDK7;H3C13;H2BC3;CDK1;NEK2;CDC25C;TP53;CENPA;CDC25A
TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,4/18,1.4117296246285428e-7,8.58017894079792e-6,0,0,113.89714285714284,1796.5315271026875,RBL2;CDK1;CDC25C;TP53
MAPK Family Signaling Cascades R-HSA-5683057,9/318,1.645415528191916e-7,9.000422939209781e-6,0,0,12.710032362459549,198.53201079543635,RAP1B;FGA;PPP2CB;MAP2K1;PRKACG;ERBB2;CDK1;FOXO3;CAMK2G
Muscarinic Acetylcholine Receptors R-HSA-390648,3/5,1.853255743701241e-7,9.215735380041625e-6,0,0,586.5882352941177,9092.79321905746,CHRM1;CHRM4;CHRM5
Generic Transcription Pathway R-HSA-212436,15/1190,3.649334321921297e-7,1.6055969942063944e-5,0,0,6.144353518821604,91.081136995921,RB1;H2BC3;CDC25C;FOXO3;ESR1;MTOR;RBL2;PPP2CB;NR4A1;CDK7;H3C13;ERBB2;CDK1;TP53;CAMK2G
PI3K/AKT Signaling In Cancer R-HSA-2219528,6/105,3.815861229375343e-7,1.6055969942063944e-5,0,0,25.05934343434344,370.3502640059448,NR4A1;BAD;ERBB2;FOXO3;ESR1;MTOR
Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,4/24,4.84388052643515e-7,1.892573319971448e-5,0,0,79.704,1158.926406855721,CDC25C;FOXO3;TP53;CDC25A
G2/M Transition R-HSA-69275,7/182,5.682794783098404e-7,1.9541628422678683e-5,0,0,16.826382978723405,241.9743664482464,PPP2CB;CDK7;CDK1;NEK2;CDC25C;TP53;CDC25A
PIP3 Activates AKT Signaling R-HSA-1257604,8/268,5.716015626377676e-7,1.9541628422678683e-5,0,0,13.167892976588629,189.2861394740072,PPP2CB;NR4A1;BAD;ERBB2;FOXO3;TP53;ESR1;MTOR
Mitotic G2-G2/M Phases R-HSA-453274,7/184,6.117213471797556e-7,1.968303393572508e-5,0,0,16.634571462916217,237.9906304936372,PPP2CB;CDK7;CDK1;NEK2;CDC25C;TP53;CDC25A
Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,4/26,6.787799980323597e-7,2.06273699402056e-5,0,0,72.4509090909091,1029.0179992254684,NR4A1;BAD;FOXO3;MTOR
RNA Polymerase II Transcription R-HSA-73857,15/1312,1.2582119177232376e-6,3.5108479911089984e-5,0,0,5.530217662060376,75.13253595405406,RB1;H2BC3;CDC25C;FOXO3;ESR1;MTOR;RBL2;PPP2CB;NR4A1;CDK7;H3C13;ERBB2;CDK1;TP53;CAMK2G
G1/S Transition R-HSA-69206,6/129,1.2836738541531983e-6,3.5108479911089984e-5,0,0,20.145325203252032,273.2871382267476,RB1;RBL2;PPP2CB;CDK7;CDK1;CDC25A
Cytokine Signaling In Immune System R-HSA-1280215,11/702,2.226092345424253e-6,5.798440537843173e-5,0,0,7.12836132332649,92.77749610653656,RAP1B;PPP2CB;MAP2K1;ANXA1;H3C13;RPS6KA1;CD27;FOXO3;TP53;CAMK2G;EIF4E
Regulation Of TP53 Degradation R-HSA-6804757,4/36,2.6215669803211103e-6,6.518168810162033e-5,0,0,49.785,639.8237930020133,PPP2CB;CDK1;TP53;MTOR
Mitotic G1 Phase And G1/S Transition R-HSA-453279,6/147,2.74838169151358e-6,6.53636863155621e-5,0,0,17.55762411347518,224.81656803084277,RB1;RBL2;PPP2CB;CDK7;CDK1;CDC25A
Regulation Of TP53 Expression And Degradation R-HSA-6806003,4/37,2.9334648248597256e-6,6.685855246659458e-5,0,0,48.27393939393939,614.977465701497,PPP2CB;CDK1;TP53;MTOR
Signaling By RAF1 Mutants R-HSA-9656223,4/38,3.2720333619200285e-6,7.159208995881022e-5,0,0,46.85176470588235,591.7424238936626,RAP1B;FGA;MAP2K1;CAMK2G
Gene Expression (Transcription) R-HSA-74160,15/1449,4.316514160468941e-6,9.04011711554742e-5,0,0,4.96513249651325,61.33459149774903,RB1;H2BC3;CDC25C;FOXO3;ESR1;MTOR;RBL2;PPP2CB;NR4A1;CDK7;H3C13;ERBB2;CDK1;TP53;CAMK2G
Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,4/41,4.462215029612072e-6,9.04011711554742e-5,0,0,43.04648648648649,530.3269139382191,RAP1B;FGA;MAP2K1;CAMK2G
Condensation Of Prophase Chromosomes R-HSA-2299718,4/43,5.416073262819622e-6,1.0580685981294046e-4,0,0,40.8348717948718,495.1693516588297,RB1;H3C13;H2BC3;CDK1
Cyclin D Associated Events In G1 R-HSA-69231,4/47,7.765565437276985e-6,1.4263392644701668e-4,0,0,37.02883720930232,435.6743107189521,RB1;RBL2;PPP2CB;CDK7
Cell Cycle Checkpoints R-HSA-69620,7/271,7.977959928106418e-6,1.4263392644701668e-4,0,0,11.10364281108962,130.34375121514148,PPP2CB;H2BC3;CDK1;CDC25C;TP53;CENPA;CDC25A
Immune System R-HSA-168256,17/1943,8.08345835440131e-6,1.4263392644701668e-4,0,0,4.298784766074486,50.40622082301679,VASP;FGA;MAP2K1;ANXA1;C1R;FOXO3;MTOR;RAP1B;PPP2CB;PFKL;H3C13;PRKACG;RPS6KA1;CD27;TP53;CAMK2G;EIF4E
TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,4/49,9.187767509359671e-6,1.525108653454651e-4,0,0,35.379555555555555,410.31926297518726,RBL2;CDK1;CDC25C;TP53
MAPK1/MAPK3 Signaling R-HSA-5684996,7/277,9.200838311518004e-6,1.525108653454651e-4,0,0,10.853585500394011,125.86052137297412,RAP1B;FGA;PPP2CB;MAP2K1;ERBB2;CDK1;CAMK2G
Mitotic Prophase R-HSA-68875,5/112,1.279217637388635e-5,1.9992344218616663e-4,0,0,18.919511729925617,213.16002377461515,RB1;PPP2CB;H3C13;H2BC3;CDK1
MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,5/112,1.279217637388635e-5,1.9992344218616663e-4,0,0,18.919511729925617,213.16002377461515,FGA;PPP2CB;MAP2K1;RPS6KA1;TP53
Signaling By BRAF And RAF1 Fusions R-HSA-6802952,4/62,2.357033247981355e-5,3.534318459257637e-4,0,0,27.431724137931035,292.29933278180096,RAP1B;FGA;MAP2K1;CAMK2G
Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,3/21,2.3906724495892608e-5,3.534318459257637e-4,0,0,65.12418300653594,693.0092755644479,CDC25C;FOXO3;CDC25A
Signaling By Interleukins R-HSA-449147,8/453,2.717271659341574e-5,3.87509465741256e-4,0,0,7.621299462628237,80.12498595395527,RAP1B;PPP2CB;MAP2K1;ANXA1;H3C13;RPS6KA1;FOXO3;TP53
E2F Mediated Regulation Of DNA Replication R-HSA-113510,3/22,2.76286456378592e-5,3.87509465741256e-4,0,0,61.69349845201239,647.57551940516,RB1;PPP2CB;CDK1
Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,5/140,3.755266771801947e-5,5.135327310439163e-4,0,0,14.974300831443689,152.58462355031946,FGA;PPP2CB;MAP2K1;RPS6KA1;TP53
Transcriptional Regulation By TP53 R-HSA-3700989,7/354,4.4433424720908914e-5,5.928069103009068e-4,0,0,8.412103746397694,84.30205384601058,RBL2;PPP2CB;CDK7;CDK1;CDC25C;TP53;MTOR
G2/M Checkpoints R-HSA-69481,5/148,4.897089856257623e-5,6.377876550887904e-4,0,0,14.130869130869131,140.23876327090272,H2BC3;CDK1;CDC25C;TP53;CDC25A
Signaling By Receptor Tyrosine Kinases R-HSA-9006934,8/496,5.164463663303946e-5,6.461780636397746e-4,0,0,6.934426229508197,68.450582625392,RAP1B;PPP2CB;MAP2K1;PRKACG;RPS6KA1;ERBB2;ESR1;MTOR
G0 And Early G1 R-HSA-1538133,3/27,5.197776014652666e-5,6.461780636397746e-4,0,0,48.82843137254902,481.6775642813018,RBL2;CDK1;CDC25A
G2/M DNA Damage Checkpoint R-HSA-69473,4/77,5.549248819159771e-5,6.745420231289766e-4,0,0,21.7786301369863,213.41452218943027,H2BC3;CDK1;CDC25C;TP53
Oncogenic MAPK Signaling R-HSA-6802957,4/78,5.837547473476775e-5,6.941605365199556e-4,0,0,21.483243243243244,209.431861088996,RAP1B;FGA;MAP2K1;CAMK2G
G1/S-Specific Transcription R-HSA-69205,3/29,6.468471964071802e-5,7.528200349675054e-4,0,0,45.067873303167424,434.7240549593,RBL2;CDK1;CDC25A
M Phase R-HSA-68886,7/380,6.944392457913388e-5,7.913713905163799e-4,0,0,7.815355655695625,74.83195984353958,RB1;PPP2CB;H3C13;H2BC3;CDK1;NEK2;CENPA
Cyclin E Associated Events During G1/S Transition R-HSA-69202,4/82,7.101006813328604e-5,7.927042299777033e-4,0,0,20.3774358974359,194.65930542836236,RB1;RBL2;CDK7;CDC25A
Toll-like Receptor Cascades R-HSA-168898,5/162,7.523100403864579e-5,8.207507716190684e-4,0,0,12.861692447679708,122.12108971879849,FGA;PPP2CB;MAP2K1;RPS6KA1;TP53
Neuronal System R-HSA-112316,7/386,7.660464843636836e-5,8.207507716190684e-4,0,0,7.689271880087577,72.87009773532044,KCNB1;PRKACG;CACNA2D1;RPS6KA1;KCNA2;KCNA3;CAMK2G
Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,4/84,7.802383934952753e-5,8.207507716190684e-4,0,0,19.866,187.9024844222236,RB1;RBL2;CDK7;CDC25A
Cellular Senescence R-HSA-2559583,5/165,8.205077164274077e-5,8.468258884637585e-4,0,0,12.618622448979592,118.71817464202935,RB1;H3C13;H2BC3;RPS6KA1;TP53
RAF Activation R-HSA-5673000,3/32,8.730265461115491e-5,8.717920922132499e-4,0,0,40.39959432048681,377.5798478482845,PPP2CB;MAP2K1;CAMK2G
RAF/MAP Kinase Cascade R-HSA-5673001,6/271,8.765734016769423e-5,8.717920922132499e-4,0,0,9.283490566037736,86.72706704243019,RAP1B;FGA;PPP2CB;MAP2K1;ERBB2;CAMK2G
Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,3/33,9.584978061048583e-5,9.36246964177424e-4,0,0,39.05098039215687,361.3281144382021,RAP1B;FGA;MAP2K1
MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,4/96,1.311542474783222e-4,0.001258620585449864,0,0,17.264347826086958,154.32836120975313,PPP2CB;MAP2K1;RPS6KA1;TP53
MAP2K And MAPK Activation R-HSA-5674135,3/37,1.354635173682446e-4,0.0012775611034556865,0,0,34.449826989619375,306.83800146502136,RAP1B;FGA;MAP2K1
Ovarian Tumor Domain Proteases R-HSA-5689896,3/39,1.5872402611939582e-4,0.0014550103223204538,0,0,32.532679738562095,284.6070589086672,CDK1;ESR1;TP53
TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,4/101,1.5959893846293825e-4,0.0014550103223204538,0,0,16.370309278350515,143.12310157439435,PPP2CB;MAP2K1;RPS6KA1;TP53
MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,4/102,1.657823674426373e-4,0.001471234841257947,0,0,16.202448979591836,141.03963960469565,PPP2CB;MAP2K1;RPS6KA1;TP53
Amine Ligand-Binding Receptors R-HSA-375280,3/40,1.7126647861235585e-4,0.001471234841257947,0,0,31.65182829888712,274.4938296061941,CHRM1;CHRM4;CHRM5
Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,4/103,1.7213716607039967e-4,0.001471234841257947,0,0,16.037979797979798,139.00468197270968,PPP2CB;MAP2K1;RPS6KA1;TP53
Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,4/103,1.7213716607039967e-4,0.001471234841257947,0,0,16.037979797979798,139.00468197270968,PPP2CB;MAP2K1;RPS6KA1;TP53
Integration Of Energy Metabolism R-HSA-163685,4/105,1.8537219531338683e-4,0.0015599783205603476,0,0,15.71881188118812,135.07402795315318,PPP2CB;MARCKS;KCNB1;PRKACG
Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,4/106,1.9225811730974157e-4,0.0015934119722489184,0,0,15.563921568627451,133.1753676598531,PPP2CB;MAP2K1;RPS6KA1;TP53
MyD88-independent TLR4 Cascade R-HSA-166166,4/107,1.99326791310776e-4,0.0016273396245820066,0,0,15.412038834951456,131.31927733074235,PPP2CB;MAP2K1;RPS6KA1;TP53
Voltage Gated Potassium Channels R-HSA-1296072,3/43,2.127063548179621e-4,0.001711034942432725,0,0,29.273529411764702,247.5251955555713,KCNB1;KCNA2;KCNA3
GPCR Downstream Signaling R-HSA-388396,8/619,2.3838983242528944e-4,0.0018898440338642511,0,0,5.50345122037999,45.90760671219674,PPP2CB;CHRM1;ANXA1;CHRM4;PRKACG;CHRM5;RPS6KA1;CAMK2G
AKT Phosphorylates Targets In Nucleus R-HSA-198693,2/10,3.175455329863666e-4,0.0024124639797714243,0,0,95.85576923076924,772.1076136521657,NR4A1;FOXO3
MAPK3 (ERK1) Activation R-HSA-110056,2/10,3.175455329863666e-4,0.0024124639797714243,0,0,95.85576923076924,772.1076136521657,MAP2K1;CDK1
MASTL Facilitates Mitotic Progression R-HSA-2465910,2/10,3.175455329863666e-4,0.0024124639797714243,0,0,95.85576923076924,772.1076136521657,PPP2CB;CDK1
"Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",2/12,4.641239039697884e-4,0.0034777503489243048,0,0,76.67692307692307,588.5229121650322,PPP2CB;PRKACG
Signaling By GPCR R-HSA-372790,8/689,4.882812554280867e-4,0.003609322252961668,0,0,4.91987486432995,37.51217124540565,PPP2CB;CHRM1;ANXA1;CHRM4;PRKACG;CHRM5;RPS6KA1;CAMK2G
RNA Polymerase I Promoter Escape R-HSA-73772,3/59,5.434871479572364e-4,0.003839951047899783,0,0,20.892857142857142,157.06214755785058,CDK7;H3C13;H2BC3
Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,2/13,5.475615753860751e-4,0.003839951047899783,0,0,69.7027972027972,523.4704909315706,CDK1;CDC25C
TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,2/13,5.475615753860751e-4,0.003839951047899783,0,0,69.7027972027972,523.4704909315706,ERBB2;ESR1
Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,2/13,5.475615753860751e-4,0.003839951047899783,0,0,69.7027972027972,523.4704909315706,RB1;PPP2CB
Post NMDA Receptor Activation Events R-HSA-438064,3/61,5.993951838136862e-4,0.00409836456932608,0,0,20.17038539553753,149.65597844366508,PRKACG;RPS6KA1;CAMK2G
DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,3/61,5.993951838136862e-4,0.00409836456932608,0,0,20.17038539553753,149.65597844366508,RB1;H2BC3;TP53
Pre-NOTCH Transcription And Translation R-HSA-1912408,3/62,6.286745850183041e-4,0.004143192747048341,0,0,19.82751744765703,146.1664121873704,H3C13;H2BC3;TP53
RHO GTPases Activate PKNs R-HSA-5625740,3/62,6.286745850183041e-4,0.004143192747048341,0,0,19.82751744765703,146.1664121873704,H3C13;H2BC3;CDC25C
MAP Kinase Activation R-HSA-450294,3/62,6.286745850183041e-4,0.004143192747048341,0,0,19.82751744765703,146.1664121873704,PPP2CB;MAP2K1;RPS6KA1
GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,2/15,7.345555571872974e-4,0.004727081056252373,0,0,58.97337278106509,425.56630208545965,RAP1B;FGA
p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,2/15,7.345555571872974e-4,0.004727081056252373,0,0,58.97337278106509,425.56630208545965,RAP1B;FGA
RHO GTPase Effectors R-HSA-195258,5/269,7.830790302299866e-4,0.004980746855067473,0,0,7.607452071737786,54.41060398271134,PPP2CB;H3C13;H2BC3;CDC25C;CENPA
Polo-like Kinase Mediated Events R-HSA-156711,2/16,8.380409440356887e-4,0.005104604301509203,0,0,54.75824175824176,387.9316753410176,CDC25C;CDC25A
Rap1 Signaling R-HSA-392517,2/16,8.380409440356887e-4,0.005104604301509203,0,0,54.75824175824176,387.9316753410176,RAP1B;PRKACG
Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,2/16,8.380409440356887e-4,0.005104604301509203,0,0,54.75824175824176,387.9316753410176,RBL2;CDK1
Regulation Of TP53 Activity R-HSA-5633007,4/157,8.51733122201485e-4,0.005104604301509203,0,0,10.349281045751631,73.15117449228809,PPP2CB;CDK1;TP53;MTOR
Glycolysis R-HSA-70171,3/69,8.59406908989732e-4,0.005104604301509203,0,0,17.718360071301248,125.07865310256418,PPP2CB;PFKL;PRKACG
Interleukin-17 Signaling R-HSA-448424,3/69,8.59406908989732e-4,0.005104604301509203,0,0,17.718360071301248,125.07865310256418,PPP2CB;MAP2K1;RPS6KA1
Hemostasis R-HSA-109582,7/576,8.678760512620765e-4,0.005104604301509203,0,0,5.071944060127884,35.75447515085943,RAP1B;FGA;PPP2CB;H3C13;PRKACG;PDE5A;TP53
Deubiquitination R-HSA-5688426,5/279,9.221915014204956e-4,0.00534671751045721,0,0,7.326083718158796,51.20022365754,H2BC3;CDK1;TP53;ESR1;CDC25A
S Phase R-HSA-69242,4/161,9.3534820473278e-4,0.00534671751045721,0,0,10.083566878980893,70.32876172465515,RB1;RBL2;CDK7;CDC25A
FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,2/17,9.481382056935088e-4,0.00534671751045721,0,0,51.1051282051282,355.7433227832543,RBL2;FOXO3
Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,2/17,9.481382056935088e-4,0.00534671751045721,0,0,51.1051282051282,355.7433227832543,RB1;TP53
Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,3/74,0.0010532263323694356,0.00581934145258668,0,0,16.466445733222866,112.89225801743812,PRKACG;RPS6KA1;CAMK2G
NoRC Negatively Regulates rRNA Expression R-HSA-427413,3/74,0.0010532263323694356,0.00581934145258668,0,0,16.466445733222866,112.89225801743812,CDK7;H3C13;H2BC3
Regulation Of Insulin Secretion R-HSA-422356,3/77,0.0011817409235949689,0.006371091335300287,0,0,15.796502384737678,106.4805351789864,MARCKS;KCNB1;PRKACG
Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,3/77,0.0011817409235949689,0.006371091335300287,0,0,15.796502384737678,106.4805351789864,CDK7;H3C13;H2BC3
Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,2/19,0.0011880280003667813,0.006371091335300287,0,0,45.088235294117645,303.6900273416844,RBL2;CDC25A
Pre-NOTCH Expression And Processing R-HSA-1912422,3/78,0.0012266757695145692,0.006451842749273745,0,0,15.585098039215689,104.47388484707804,H3C13;H2BC3;TP53
RNA Polymerase I Promoter Clearance R-HSA-73854,3/78,0.0012266757695145692,0.006451842749273745,0,0,15.585098039215689,104.47388484707804,CDK7;H3C13;H2BC3
Amyloid Fiber Formation R-HSA-977225,3/79,0.0012726750607539453,0.006567483568230265,0,0,15.379256965944272,102.52788117796472,FGA;H3C13;H2BC3
RNA Polymerase I Transcription R-HSA-73864,3/79,0.0012726750607539453,0.006567483568230265,0,0,15.379256965944272,102.52788117796472,CDK7;H3C13;H2BC3
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,3/81,0.0013679049969355808,0.006992934890876286,0,0,14.98340874811463,98.80771303890248,H3C13;H2BC3;RPS6KA1
TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,2/21,0.0014539455822740843,0.007363965125036335,0,0,40.33805668016194,263.5476577125423,CDC25C;TP53
G Alpha (I) Signaling Events R-HSA-418594,5/312,0.0015139663668674354,0.00759761103372924,0,0,6.5276208203150965,42.38398780659462,PPP2CB;ANXA1;CHRM4;PRKACG;CAMK2G
Mitotic Prometaphase R-HSA-68877,4/186,0.0015935195362696236,0.007867821715140133,0,0,8.687472527472528,55.96304882874485,PPP2CB;CDK1;NEK2;CENPA
ERK/MAPK Targets R-HSA-198753,2/22,0.0015965780811344696,0.007867821715140133,0,0,38.31923076923077,246.7717321748194,PPP2CB;RPS6KA1
ESR-mediated Signaling R-HSA-8939211,4/188,0.0016571566484326213,0.00806159451621034,0,0,8.592173913043478,55.012699554251626,H3C13;H2BC3;FOXO3;ESR1
Innate Immune System R-HSA-168249,9/1035,0.0016701123024465882,0.00806159451621034,0,0,3.688109161793372,23.584958010982696,RAP1B;FGA;PPP2CB;MAP2K1;PFKL;C1R;PRKACG;RPS6KA1;TP53
APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,3/87,0.0016801129339085537,0.00806159451621034,0,0,13.908963585434174,88.86289768671406,RB1;CDK1;NEK2
Opioid Signaling R-HSA-111885,3/88,0.0017361096774850563,0.008231471687015664,0,0,13.744636678200692,87.36240183368733,PPP2CB;PRKACG;CAMK2G
RAF-independent MAPK1/3 Activation R-HSA-112409,2/23,0.001745613739842444,0.008231471687015664,0,0,36.49267399267399,231.752166218624,MAP2K1;CDK1
Glucose Metabolism R-HSA-70326,3/89,0.001793261921908923,0.008383882660548557,0,0,13.584131326949384,85.9022295713123,PPP2CB;PFKL;PRKACG
MAPK6/MAPK4 Signaling R-HSA-5687128,3/90,0.00185157826534906,0.008583163653779114,0,0,13.42731575388776,84.480869278287,PRKACG;CDK1;FOXO3
DARPP-32 Events R-HSA-180024,2/24,0.001901018240228249,0.008665474811707102,0,0,34.83216783216783,218.23626682147088,PPP2CB;PRKACG
mTORC1-mediated Signaling R-HSA-166208,2/24,0.001901018240228249,0.008665474811707102,0,0,34.83216783216783,218.23626682147088,EIF4E;MTOR
Oxidative Stress Induced Senescence R-HSA-2559580,3/93,0.002033596518985928,0.009193200792440518,0,0,12.977777777777778,80.43560959243626,H3C13;H2BC3;TP53
Developmental Biology R-HSA-1266738,9/1073,0.0021382083629319683,0.00958688503708022,0,0,3.549248120300752,21.82002150412533,VASP;MAP2K1;H3C13;PRKACG;H2BC3;RPS6KA1;ERBB2;DCX;FOXO3
Transcriptional Regulation By RUNX1 R-HSA-8878171,4/204,0.002231333661600401,0.00992308547069447,0,0,7.8984,48.22096271087017,CDK7;H3C13;H2BC3;ESR1
RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,3/98,0.00236101878717659,0.010415139327303183,0,0,12.291640866873063,74.34798181102396,CDK7;H3C13;H2BC3
CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,2/27,0.002405103597341798,0.01044120371226955,0,0,30.647692307692303,184.81055875222285,RPS6KA1;CAMK2G
Integrin Signaling R-HSA-354192,2/27,0.002405103597341798,0.01044120371226955,0,0,30.647692307692303,184.81055875222285,RAP1B;FGA
L1CAM Interactions R-HSA-373760,3/99,0.0024301842046651166,0.010467013857888336,0,0,12.16299019607843,73.21862510371197,MAP2K1;RPS6KA1;DCX
G Alpha (Q) Signaling Events R-HSA-416476,4/212,0.0025643944803848146,0.01095877953726948,0,0,7.591538461538462,45.29136820989699,CHRM1;ANXA1;CHRM5;RPS6KA1
Potassium Channels R-HSA-1296071,3/102,0.0026451820800154568,0.011216392230763216,0,0,11.79263220439691,69.9894534650505,KCNB1;KCNA2;KCNA3
Axon Guidance R-HSA-422475,6/519,0.002667425698852273,0.01122370659440149,0,0,4.735136452241715,28.063455871728557,VASP;MAP2K1;PRKACG;RPS6KA1;ERBB2;DCX
"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",3/106,0.002949629109110639,0.01210456201528527,0,0,11.332381496287836,66.02331407079404,PPP2CB;ERBB2;ESR1
Resolution Of Sister Chromatid Cohesion R-HSA-2500257,3/106,0.002949629109110639,0.01210456201528527,0,0,11.332381496287836,66.02331407079404,PPP2CB;CDK1;CENPA
Activation Of BH3-only Proteins R-HSA-114452,2/30,0.0029652857587718945,0.01210456201528527,0,0,27.35989010989011,159.25595242218557,BAD;TP53
MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,2/30,0.0029652857587718945,0.01210456201528527,0,0,27.35989010989011,159.25595242218557,PPP2CB;RPS6KA1
Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,3/107,0.0030289650744002505,0.012272917745903238,0,0,11.222850678733032,65.08730720156075,ANXA1;FOXO3;TP53
Cellular Responses To Stress R-HSA-2262752,7/722,0.003143598362320783,0.012643737530804914,0,0,4.0058622228835,23.08332903758854,RB1;H3C13;H2BC3;RPS6KA1;TP53;CAMK2G;MTOR
RNA Polymerase I Promoter Opening R-HSA-73728,2/32,0.003369457930597071,0.013453237138953269,0,0,25.53333333333333,145.3613534547405,H3C13;H2BC3
Nervous System Development R-HSA-9675108,6/545,0.0033953356623193814,0.013458323241222475,0,0,4.50069573283859,25.588042426167934,VASP;MAP2K1;PRKACG;RPS6KA1;ERBB2;DCX
Cellular Responses To Stimuli R-HSA-8953897,7/736,0.003495321969714777,0.013754972067870382,0,0,3.926071855937892,22.20715717517468,RB1;H3C13;H2BC3;RPS6KA1;TP53;CAMK2G;MTOR
Negative Regulation Of PI3K/AKT Network R-HSA-199418,3/113,0.00353260376693805,0.01379310356274259,0,0,10.607486631016044,59.88690015339679,PPP2CB;ERBB2;ESR1
Oncogene Induced Senescence R-HSA-2559585,2/33,0.003580659425794237,0.01379310356274259,0,0,24.70843672456576,139.16306236015848,RB1;TP53
CaM Pathway R-HSA-111997,2/33,0.003580659425794237,0.01379310356274259,0,0,24.70843672456576,139.16306236015848,PRKACG;CAMK2G
Signaling By NTRK1 (TRKA) R-HSA-187037,3/114,0.003621210497269949,0.013851763230815816,0,0,10.511393746687864,59.08398627938719,PPP2CB;MAP2K1;RPS6KA1
DNA Methylation R-HSA-5334118,2/34,0.003797893801950445,0.01434454037320183,0,0,23.935096153846157,133.3976779195181,H3C13;H2BC3
Epigenetic Regulation Of Gene Expression R-HSA-212165,3/116,0.0038024832799163897,0.01434454037320183,0,0,10.32431025507548,57.52809878392557,CDK7;H3C13;H2BC3
Ca-dependent Events R-HSA-111996,2/35,0.0040211281759028085,0.015065459672731756,0,0,23.208624708624708,128.02324793427923,PRKACG;CAMK2G
Estrogen-dependent Gene Expression R-HSA-9018519,3/119,0.004084635694037895,0.015096592734045466,0,0,10.05578093306288,55.31205165088091,H3C13;H2BC3;ESR1
Transcriptional Regulation By RUNX2 R-HSA-8878166,3/119,0.004084635694037895,0.015096592734045466,0,0,10.05578093306288,55.31205165088091,RB1;CDK1;ESR1
Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,2/36,0.004250329791188123,0.015195623501829432,0,0,22.524886877828056,123.00297201006306,H3C13;H2BC3
Activation Of ATR In Response To Replication Stress R-HSA-176187,2/36,0.004250329791188123,0.015195623501829432,0,0,22.524886877828056,123.00297201006306,CDC25C;CDC25A
Platelet Aggregation (Plug Formation) R-HSA-76009,2/36,0.004250329791188123,0.015195623501829432,0,0,22.524886877828056,123.00297201006306,RAP1B;FGA
Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,2/36,0.004250329791188123,0.015195623501829432,0,0,22.524886877828056,123.00297201006306,ERBB2;ESR1
HSF1-dependent Transactivation R-HSA-3371571,2/36,0.004250329791188123,0.015195623501829432,0,0,22.524886877828056,123.00297201006306,CAMK2G;MTOR
Transmission Across Chemical Synapses R-HSA-112315,4/246,0.004363639306097275,0.015499420132696165,0,0,6.513719008264463,35.39847288154587,PRKACG;CACNA2D1;RPS6KA1;CAMK2G
SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,2/37,0.004485466019866562,0.01582935427656135,0,0,21.88021978021978,118.30444220257536,H3C13;H2BC3
Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,2/38,0.0047265043601269615,0.016573063365316974,0,0,21.271367521367523,113.8990133200568,H3C13;H2BC3
DAG And IP3 Signaling R-HSA-1489509,2/39,0.004973412437192558,0.01732774906461356,0,0,20.695426195426197,109.76127784080532,PRKACG;CAMK2G
Signaling By Nuclear Receptors R-HSA-9006931,4/260,0.005303339592729122,0.01836029593179006,0,0,6.153125,32.23879723485995,H3C13;H2BC3;FOXO3;ESR1
Signaling By NTRKs R-HSA-166520,3/132,0.005453058494504465,0.01863438376263526,0,0,9.036479708162334,47.09432459228409,PPP2CB;MAP2K1;RPS6KA1
MTOR Signaling R-HSA-165159,2/41,0.005484708931963944,0.01863438376263526,0,0,19.63214990138067,102.20087423124885,EIF4E;MTOR
Negative Regulation Of MAPK Pathway R-HSA-5675221,2/41,0.005484708931963944,0.01863438376263526,0,0,19.63214990138067,102.20087423124885,PPP2CB;MAP2K1
PRC2 Methylates Histones And DNA R-HSA-212300,2/42,0.005749033228634364,0.01917512912233535,0,0,19.140384615384612,98.73995330132682,H3C13;H2BC3
Defective Pyroptosis R-HSA-9710421,2/42,0.005749033228634364,0.01917512912233535,0,0,19.140384615384612,98.73995330132682,H3C13;H2BC3
Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,2/42,0.005749033228634364,0.01917512912233535,0,0,19.140384615384612,98.73995330132682,KCNB1;PRKACG
Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,3/136,0.00592302423581456,0.01963572276963978,0,0,8.762936753648829,44.944297382169374,H3C13;PRKACG;TP53
Smooth Muscle Contraction R-HSA-445355,2/43,0.006019099019507137,0.019834019058255447,0,0,18.672607879924957,95.46963998767032,ANXA1;PDE5A
ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,2/45,0.006576328212641212,0.02154042833721403,0,0,17.802325581395348,89.44384543900023,H3C13;H2BC3
PLC Beta Mediated Events R-HSA-112043,2/47,0.007156144010234874,0.02330006412856236,0,0,17.00940170940171,84.0227702288541,PRKACG;CAMK2G
Metabolism Of Carbohydrates R-HSA-71387,4/285,0.007302425036144574,0.023635659732373263,0,0,5.598576512455516,27.54247030343435,GYS2;PPP2CB;PFKL;PRKACG
Signaling By Rho GTPases R-HSA-194315,6/644,0.0075762914476708515,0.024377831893387977,0,0,3.7829153605015673,18.470959818452947,PPP2CB;H3C13;H2BC3;PDE5A;CDC25C;CENPA
"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",6/660,0.00849979417005342,0.02718940006443989,0,0,3.687308868501529,17.580031648115924,PPP2CB;H3C13;H2BC3;PDE5A;CDC25C;CENPA
G-protein Mediated Events R-HSA-112040,2/52,0.008702860592001184,0.027677120603631672,0,0,15.304615384615383,72.6066794687417,PRKACG;CAMK2G
Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,2/53,0.009028615477782772,0.02838306130084584,0,0,15.003770739064857,70.62809393251956,H2BC3;CENPA
Nuclear Receptor Transcription Pathway R-HSA-383280,2/53,0.009028615477782772,0.02838306130084584,0,0,15.003770739064857,70.62809393251956,NR4A1;ESR1
Intrinsic Pathway For Apoptosis R-HSA-109606,2/55,0.009696291882368669,0.030307838055175205,0,0,14.436139332365748,66.92611152225938,BAD;TP53
Meiotic Recombination R-HSA-912446,2/56,0.010038152704654208,0.031198122326396883,0,0,14.168091168091168,65.19251879575016,H3C13;H2BC3
B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,2/59,0.011095463990631825,0.03390625029539445,0,0,13.42037786774629,60.40805855278045,H3C13;H2BC3
Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,2/59,0.011095463990631825,0.03390625029539445,0,0,13.42037786774629,60.40805855278045,CDK1;TP53
Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,2/59,0.011095463990631825,0.03390625029539445,0,0,13.42037786774629,60.40805855278045,H3C13;H2BC3
Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,2/60,0.011458377583512931,0.03443809086912953,0,0,13.188328912466844,58.93909228909847,H2BC3;TP53
Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,2/60,0.011458377583512931,0.03443809086912953,0,0,13.188328912466844,58.93909228909847,H3C13;H2BC3
HDACs Deacetylate Histones R-HSA-3214815,2/60,0.011458377583512931,0.03443809086912953,0,0,13.188328912466844,58.93909228909847,H3C13;H2BC3
Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,4/327,0.01168119718899368,0.03478002403842313,0,0,4.860185758513932,21.62673214935208,CHRM1;ANXA1;CHRM4;CHRM5
Regulation Of PTEN Gene Transcription R-HSA-8943724,2/61,0.011826479837562529,0.03478002403842313,0,0,12.964146023468055,57.52728575404862,TP53;MTOR
DNA Double Strand Break Response R-HSA-5693606,2/61,0.011826479837562529,0.03478002403842313,0,0,12.964146023468055,57.52728575404862,H2BC3;TP53
Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,2/61,0.011826479837562529,0.03478002403842313,0,0,12.964146023468055,57.52728575404862,PPP2CB;RPS6KA1
TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,2/62,0.012199741169170162,0.035685873901262453,0,0,12.747435897435896,56.16954361556468,CDK7;TP53
Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,3/182,0.013088782451351883,0.037476506354727546,0,0,6.495892211633256,28.16618679152545,PRKACG;RPS6KA1;CAMK2G
FOXO-mediated Transcription R-HSA-9614085,2/65,0.013350185600004118,0.037476506354727546,0,0,12.138583638583638,52.39285806360887,RBL2;FOXO3
PKA-mediated Phosphorylation Of Key Metabolic Factors R-HSA-163358,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,PRKACG
Activation Of NOXA And Translocation To Mitochondria R-HSA-111448,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,TP53
RUNX3 Regulates BCL2L11 (BIM) Transcription R-HSA-8952158,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,FOXO3
SARS-CoV-1 Genome Replication And Transcription R-HSA-9679514,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,RB1
SARS-CoV-2 Genome Replication And Transcription R-HSA-9694682,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,RB1
G2/M DNA Replication Checkpoint R-HSA-69478,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,CDK1
GRB7 Events In ERBB2 Signaling R-HSA-1306955,1/5,0.013428510503704937,0.037476506354727546,0,0,94.06603773584904,405.4599145949008,ERBB2
RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,2/66,0.013743789789728369,0.03803174599243688,0,0,11.948317307692308,51.22444610721821,H3C13;H2BC3
Adaptive Immune System R-HSA-1280218,6/733,0.013766518659053937,0.03803174599243688,0,0,3.3045048143053646,14.161507655334743,RAP1B;VASP;FGA;PPP2CB;PRKACG;MTOR
G1/S DNA Damage Checkpoints R-HSA-69615,2/67,0.01414240690271311,0.03887385213961845,0,0,11.763905325443789,50.09750151432616,TP53;CDC25A
Costimulation By CD28 Family R-HSA-388841,2/68,0.014546008060224129,0.03978333204471299,0,0,11.585081585081586,49.00997728474978,PPP2CB;MTOR
Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,2/69,0.01495456448996044,0.04069724764183264,0,0,11.411595866819749,47.959955677421554,CDK1;NEK2
Muscle Contraction R-HSA-397014,3/196,0.015941665935905514,0.04252569940310359,0,0,6.020420603474551,24.91743177263826,ANXA1;PDE5A;CAMK2G
Phosphorylation Of Emi1 R-HSA-176417,1/6,0.016092906355470643,0.04252569940310359,0,0,75.24905660377358,310.73170127161313,CDK1
RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,1/6,0.016092906355470643,0.04252569940310359,0,0,75.24905660377358,310.73170127161313,ESR1
RUNX1 Regulates Transcription Of Genes Involved In WNT Signaling R-HSA-8939256,1/6,0.016092906355470643,0.04252569940310359,0,0,75.24905660377358,310.73170127161313,ESR1
Classical Antibody-Mediated Complement Activation R-HSA-173623,1/6,0.016092906355470643,0.04252569940310359,0,0,75.24905660377358,310.73170127161313,C1R
Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,1/6,0.016092906355470643,0.04252569940310359,0,0,75.24905660377358,310.73170127161313,MAP2K1
AURKA Activation By TPX2 R-HSA-8854518,2/72,0.016209679409403953,0.04262833960069213,0,0,10.92087912087912,45.0174660560013,CDK1;NEK2
TCF Dependent Signaling In Response To WNT R-HSA-201681,3/198,0.016375572804880743,0.04285855657545343,0,0,5.9580693815987935,24.49936989066364,PPP2CB;H3C13;H2BC3
APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,2/73,0.016637771492323223,0.04313204268389007,0,0,10.76652221018418,44.10053389696503,CDK1;NEK2
Extra-nuclear Estrogen Signaling R-HSA-9009391,2/73,0.016637771492323223,0.04313204268389007,0,0,10.76652221018418,44.10053389696503,FOXO3;ESR1
Ub-specific Processing Proteases R-HSA-5689880,3/201,0.017038853362367944,0.04383878007526814,0,0,5.8669043374925725,23.89155428844949,H2BC3;TP53;CDC25A
Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,2/74,0.017070676702069677,0.04383878007526814,0,0,10.616452991452991,43.21313700492695,H3C13;H2BC3
Signaling By NOTCH R-HSA-157118,3/203,0.01748933426983529,0.04454454285727641,0,0,5.807647058823529,23.49869276860356,H3C13;H2BC3;TP53
APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,2/75,0.01750836693658945,0.04454454285727641,0,0,10.47049525816649,42.35395328238597,CDK1;NEK2
Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,2/76,0.01795081422272284,0.04524928746465158,0,0,10.328482328482329,41.52173635894564,CDK1;NEK2
Transcriptional Regulation By Small RNAs R-HSA-5578749,2/76,0.01795081422272284,0.04524928746465158,0,0,10.328482328482329,41.52173635894564,H3C13;H2BC3
PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,PPP2CB
"Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,CDK1
CREB Phosphorylation R-HSA-199920,1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,RPS6KA1
RSK Activation R-HSA-444257,1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,RPS6KA1
RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,TP53
HDL Assembly R-HSA-8963896,1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,PRKACG
Neurofascin Interactions R-HSA-447043,1/7,0.018750240650692064,0.04578741801753821,0,0,62.70440251572328,249.34710980306107,DCX
Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,2/78,0.018849868567545856,0.045826124917544814,0,0,10.055668016194332,39.933564949004506,ERBB2;ESR1
Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,2/80,0.01976761811547072,0.047844633226382674,0,0,9.796844181459566,38.43997674508189,CDK1;NEK2
Centrosome Maturation R-HSA-380287,2/81,0.02023343481250457,0.04854249492298245,0,0,9.672346640701072,37.72620320128746,CDK1;NEK2
TP53 Regulates Metabolic Genes R-HSA-5628897,2/81,0.02023343481250457,0.04854249492298245,0,0,9.672346640701072,37.72620320128746,TP53;MTOR
Platelet Homeostasis R-HSA-418346,2/83,0.021178815458187183,0.05045728765757091,0,0,9.432573599240266,36.36024956449246,PPP2CB;PDE5A
CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,1/8,0.021400531511072123,0.05045728765757091,0,0,53.74393530997305,206.60993448840281,CAMK2G
ROBO Receptors Bind AKAP5 R-HSA-9010642,1/8,0.021400531511072123,0.05045728765757091,0,0,53.74393530997305,206.60993448840281,PRKACG
Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,1/8,0.021400531511072123,0.05045728765757091,0,0,53.74393530997305,206.60993448840281,ANXA1
Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,2/87,0.02312380768284088,0.05428636395928739,0,0,8.986877828054299,33.85260319733611,CDK1;NEK2
Meiosis R-HSA-1500620,2/88,0.023621197177979197,0.0552170720357035,0,0,8.881932021466906,33.268260367425945,H3C13;H2BC3
PI5P Regulates TP53 Acetylation R-HSA-6811555,1/9,0.02404379708967068,0.0552603235632347,0,0,47.02358490566038,175.29819860584723,TP53
Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,1/9,0.02404379708967068,0.0552603235632347,0,0,47.02358490566038,175.29819860584723,TP53
BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,1/9,0.02404379708967068,0.0552603235632347,0,0,47.02358490566038,175.29819860584723,BAD
E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,1/9,0.02404379708967068,0.0552603235632347,0,0,47.02358490566038,175.29819860584723,CDK1
Mitotic Anaphase R-HSA-68882,3/232,0.02477084901629668,0.05669311469420202,0,0,5.064731569483689,18.72982182518469,PPP2CB;CDK1;CENPA
Mitotic Metaphase And Anaphase R-HSA-2555396,3/233,0.025047011586177656,0.05682398668943352,0,0,5.042455242966752,18.59153629556091,PPP2CB;CDK1;CENPA
Activation Of HOX Genes During Differentiation R-HSA-5619507,2/91,0.02513967966881702,0.05682398668943352,0,0,8.58124459809853,31.60736531457828,H3C13;H2BC3
HCMV Late Events R-HSA-9610379,2/91,0.02513967966881702,0.05682398668943352,0,0,8.58124459809853,31.60736531457828,H3C13;H2BC3
Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,2/93,0.026173666421059647,0.05861040311785264,0,0,8.391800507185122,30.571341601228703,PPP2CB;CENPA
VEGFA-VEGFR2 Pathway R-HSA-4420097,2/93,0.026173666421059647,0.05861040311785264,0,0,8.391800507185122,30.571341601228703,PRKACG;MTOR
Acetylcholine Regulates Insulin Secretion R-HSA-399997,1/10,0.026680055532623963,0.05861040311785264,0,0,41.79664570230608,151.46431378315344,MARCKS
CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,1/10,0.026680055532623963,0.05861040311785264,0,0,41.79664570230608,151.46431378315344,CAMK2G
Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,1/10,0.026680055532623963,0.05861040311785264,0,0,41.79664570230608,151.46431378315344,FOXO3
Condensation Of Prometaphase Chromosomes R-HSA-2514853,1/10,0.026680055532623963,0.05861040311785264,0,0,41.79664570230608,151.46431378315344,CDK1
Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,1/10,0.026680055532623963,0.05861040311785264,0,0,41.79664570230608,151.46431378315344,ERBB2
Transcriptional Regulation By RUNX3 R-HSA-8878159,2/95,0.027224741521093776,0.05956773444815319,0,0,8.210504549214226,29.58761315521645,FOXO3;TP53
HCMV Early Events R-HSA-9609690,2/96,0.027756622441222227,0.06048953177429704,0,0,8.122749590834697,29.11421557002708,H3C13;H2BC3
Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,2/97,0.028292697945384224,0.06117037856175957,0,0,8.036842105263158,28.652559934038813,CDK1;NEK2
EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,2/97,0.028292697945384224,0.06117037856175957,0,0,8.036842105263158,28.652559934038813,PPP2CB;CENPA
Uptake And Function Of Anthrax Toxins R-HSA-5210891,1/11,0.02930932497110778,0.06277109253565187,0,0,37.61509433962264,132.7756240232595,MAP2K1
MET Activates RAP1 And RAC1 R-HSA-8875555,1/11,0.02930932497110778,0.06277109253565187,0,0,37.61509433962264,132.7756240232595,RAP1B
Cellular Response To Heat Stress R-HSA-3371556,2/99,0.02937733032747144,0.06277109253565187,0,0,7.870340999206978,27.76287956322896,CAMK2G;MTOR
Signaling By VEGF R-HSA-194138,2/102,0.03103510116204576,0.06605525422427638,0,0,7.633076923076923,26.50690091600009,PRKACG;MTOR
Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,1/12,0.03193162350337226,0.06641292036632937,0,0,34.19382504288165,117.768950701619,CACNA2D1
CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,1/12,0.03193162350337226,0.06641292036632937,0,0,34.19382504288165,117.768950701619,PRKACG
Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,1/12,0.03193162350337226,0.06641292036632937,0,0,34.19382504288165,117.768950701619,FOXO3
Frs2-mediated Activation R-HSA-170968,1/12,0.03193162350337226,0.06641292036632937,0,0,34.19382504288165,117.768950701619,MAP2K1
TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,1/12,0.03193162350337226,0.06641292036632937,0,0,34.19382504288165,117.768950701619,TP53
TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,1/12,0.03193162350337226,0.06641292036632937,0,0,34.19382504288165,117.768950701619,TP53
HATs Acetylate Histones R-HSA-3214847,2/106,0.03330194056047259,0.06900061169158524,0,0,7.33801775147929,24.964960840949882,H3C13;H2BC3
Gene Silencing By RNA R-HSA-211000,2/108,0.034459117430595106,0.07024978497325196,0,0,7.198838896952105,24.24555737554133,H3C13;H2BC3
Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,1/13,0.03454696920988076,0.07024978497325196,0,0,31.342767295597483,105.4820602978719,ERBB2
ERBB2 Activates PTK6 Signaling R-HSA-8847993,1/13,0.03454696920988076,0.07024978497325196,0,0,31.342767295597483,105.4820602978719,ERBB2
ERKs Are Inactivated R-HSA-202670,1/13,0.03454696920988076,0.07024978497325196,0,0,31.342767295597483,105.4820602978719,PPP2CB
Glycogen Synthesis R-HSA-3322077,1/13,0.03454696920988076,0.07024978497325196,0,0,31.342767295597483,105.4820602978719,GYS2
GPCR Ligand Binding R-HSA-500792,4/458,0.03494991722355799,0.0708059434121712,0,0,3.434713656387665,11.519477228511189,CHRM1;ANXA1;CHRM4;CHRM5
Assembly Of Pre-Replicative Complex R-HSA-68867,2/110,0.035631869982316926,0.0716567385306153,0,0,7.064814814814815,23.55772968201733,H3C13;H2BC3
Mitotic Spindle Checkpoint R-HSA-69618,2/110,0.035631869982316926,0.0716567385306153,0,0,7.064814814814815,23.55772968201733,PPP2CB;CENPA
AKT Phosphorylates Targets In Cytosol R-HSA-198323,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,BAD
APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,PPP2CB
Prolonged ERK Activation Events R-HSA-169893,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,MAP2K1
Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,TP53
Creation Of C4 And C2 Activators R-HSA-166786,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,C1R
TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,TP53
TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,TP53
Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,1/14,0.03715538012271022,0.07258568902543747,0,0,28.93033381712627,95.25736807729456,CDK1
Reproduction R-HSA-1474165,2/113,0.03741977747531487,0.0728420579323745,0,0,6.872834372834373,22.58108155659642,H3C13;H2BC3
Interleukin-1 Signaling R-HSA-9020702,2/114,0.03802332442060594,0.07375446261727464,0,0,6.811126373626373,22.269355743844745,MAP2K1;TP53
Activation Of BAD And Translocation To Mitochondria R-HSA-111447,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,BAD
CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,PPP2CB
Depolymerisation Of Nuclear Lamina R-HSA-4419969,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,CDK1
Signaling By ERBB2 ECD Mutants R-HSA-9665348,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,ERBB2
ERBB2 Regulates Cell Motility R-HSA-6785631,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,ERBB2
GRB2 Events In ERBB2 Signaling R-HSA-1963640,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,ERBB2
Glycogen Storage Diseases R-HSA-3229121,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,GYS2
cGMP Effects R-HSA-418457,1/15,0.03975687424498529,0.07498969038623088,0,0,26.862533692722373,86.63093286520242,PDE5A
Chromosome Maintenance R-HSA-73886,2/118,0.04047476414438527,0.07608142950851801,0,0,6.574933687002653,21.086316017715763,H2BC3;CENPA
RHO GTPases Activate Formins R-HSA-5663220,2/119,0.04109681871092074,0.07698616381806042,0,0,6.518408941485864,20.805617778303198,PPP2CB;CENPA
PI3K Events In ERBB2 Signaling R-HSA-1963642,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,ERBB2
PKA Activation In Glucagon Signaling R-HSA-164378,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,PRKACG
Plasma Lipoprotein Assembly R-HSA-8963898,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,PRKACG
Cell-extracellular Matrix Interactions R-HSA-446353,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,VASP
FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,FOXO3
Spry Regulation Of FGF Signaling R-HSA-1295596,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,PPP2CB
MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,1/16,0.04235146953793646,0.07722144335598306,0,0,25.07044025157233,79.26651858378708,MAP2K1
HCMV Infection R-HSA-9609646,2/121,0.04235179708737645,0.07722144335598306,0,0,6.408209437621203,20.261120461118168,H3C13;H2BC3
Infectious Disease R-HSA-5663205,6/961,0.0441084313081131,0.07996625157504135,0,0,2.4857329842931937,7.758231977215321,RB1;MAP2K1;CDK7;H3C13;PRKACG;H2BC3
Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,1/17,0.04493918392504326,0.07996625157504135,0,0,23.50235849056604,72.91477862029602,RB1
PKA Activation R-HSA-163615,1/17,0.04493918392504326,0.07996625157504135,0,0,23.50235849056604,72.91477862029602,PRKACG
Platelet Sensitization By LDL R-HSA-432142,1/17,0.04493918392504326,0.07996625157504135,0,0,23.50235849056604,72.91477862029602,PPP2CB
Beta-catenin Phosphorylation Cascade R-HSA-196299,1/17,0.04493918392504326,0.07996625157504135,0,0,23.50235849056604,72.91477862029602,PPP2CB
Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,1/17,0.04493918392504326,0.07996625157504135,0,0,23.50235849056604,72.91477862029602,RPS6KA1
MyD88 Deficiency (TLR2/4) R-HSA-5602498,1/17,0.04493918392504326,0.07996625157504135,0,0,23.50235849056604,72.91477862029602,FGA
Signaling By WNT R-HSA-195721,3/294,0.045026701069675934,0.07996625157504135,0,0,3.973115019203558,12.318641559876056,PPP2CB;H3C13;H2BC3
DNA Replication Pre-Initiation R-HSA-69002,2/127,0.04620201817185455,0.08178803864079107,0,0,6.098769230769231,18.752079685407438,H3C13;H2BC3
Regulation Of NF-kappa B Signaling R-HSA-9758274,1/18,0.04752003528742647,0.08331236955840474,0,0,22.11875693673696,67.38709029166962,TP53
Regulation Of TLR By Endogenous Ligand R-HSA-5686938,1/18,0.04752003528742647,0.08331236955840474,0,0,22.11875693673696,67.38709029166962,FGA
IRAK4 Deficiency (TLR2/4) R-HSA-5603041,1/18,0.04752003528742647,0.08331236955840474,0,0,22.11875693673696,67.38709029166962,FGA
PKA-mediated Phosphorylation Of CREB R-HSA-111931,1/19,0.05009404144634451,0.08643987593422853,0,0,20.88888888888889,62.53826707779693,PRKACG
Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,1/19,0.05009404144634451,0.08643987593422853,0,0,20.88888888888889,62.53826707779693,CAMK2G
Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,1/19,0.05009404144634451,0.08643987593422853,0,0,20.88888888888889,62.53826707779693,TP53
SUMOylation Of Transcription Factors R-HSA-3232118,1/19,0.05009404144634451,0.08643987593422853,0,0,20.88888888888889,62.53826707779693,TP53
Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,1/19,0.05009404144634451,0.08643987593422853,0,0,20.88888888888889,62.53826707779693,CDK1
DNA Repair R-HSA-73894,3/310,0.05126662433231675,0.0881850424835763,0,0,3.7629814140639968,11.178746597147123,CDK7;H2BC3;TP53
Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,1/20,0.05266122021570595,0.08890644277157764,0,0,19.788480635551142,58.25483230121243,RB1
Phosphorylation Of APC/C R-HSA-176412,1/20,0.05266122021570595,0.08890644277157764,0,0,19.788480635551142,58.25483230121243,CDK1
CD209 (DC-SIGN) Signaling R-HSA-5621575,1/20,0.05266122021570595,0.08890644277157764,0,0,19.788480635551142,58.25483230121243,PRKACG
Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,1/20,0.05266122021570595,0.08890644277157764,0,0,19.788480635551142,58.25483230121243,ERBB2
Signal Transduction By L1 R-HSA-445144,1/20,0.05266122021570595,0.08890644277157764,0,0,19.788480635551142,58.25483230121243,MAP2K1
TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,1/20,0.05266122021570595,0.08890644277157764,0,0,19.788480635551142,58.25483230121243,TP53
PTEN Regulation R-HSA-6807070,2/139,0.05426992234060185,0.0907093374452162,0,0,5.561201572150477,16.204146400763,TP53;MTOR
Branched-chain Amino Acid Catabolism R-HSA-70895,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,BCKDK
CTLA4 Inhibitory Signaling R-HSA-389513,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,PPP2CB
SHC1 Events In ERBB2 Signaling R-HSA-1250196,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,ERBB2
Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,ERBB2
"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,CAMK2G
Initial Triggering Of Complement R-HSA-166663,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,C1R
Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,CAMK2G
Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,1/21,0.05522158934050639,0.0907093374452162,0,0,18.79811320754717,54.4468793612393,PDE5A
Common Pathway Of Fibrin Clot Formation R-HSA-140875,1/22,0.05777516652888407,0.09433736146656592,0,0,17.902066486972146,51.04230466405881,FGA
Signaling By NODAL R-HSA-1181150,1/22,0.05777516652888407,0.09433736146656592,0,0,17.902066486972146,51.04230466405881,FOXO3
RHOBTB1 GTPase Cycle R-HSA-9013422,1/23,0.06032196944504943,0.09704740378365306,0,0,17.087478559176674,47.98264634686218,PDE5A
CD28 Dependent PI3K/Akt Signaling R-HSA-389357,1/23,0.06032196944504943,0.09704740378365306,0,0,17.087478559176674,47.98264634686218,MTOR
Triglyceride Catabolism R-HSA-163560,1/23,0.06032196944504943,0.09704740378365306,0,0,17.087478559176674,47.98264634686218,PRKACG
Long-term Potentiation R-HSA-9620244,1/23,0.06032196944504943,0.09704740378365306,0,0,17.087478559176674,47.98264634686218,CAMK2G
Miscellaneous Transport And Binding Events R-HSA-5223345,1/23,0.06032196944504943,0.09704740378365306,0,0,17.087478559176674,47.98264634686218,ADD2
DNA Double-Strand Break Repair R-HSA-5693532,2/149,0.06134487149537193,0.09840365016999544,0,0,5.180272108843537,14.459401916725946,H2BC3;TP53
APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,1/24,0.06286201570363556,0.09909372504290676,0,0,16.343724364232976,45.22003200693963,CDK1
RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,1/24,0.06286201570363556,0.09909372504290676,0,0,16.343724364232976,45.22003200693963,RB1
Sema4D In Semaphorin Signaling R-HSA-400685,1/24,0.06286201570363556,0.09909372504290676,0,0,16.343724364232976,45.22003200693963,ERBB2
Signaling By ERBB2 KD Mutants R-HSA-9664565,1/24,0.06286201570363556,0.09909372504290676,0,0,16.343724364232976,45.22003200693963,ERBB2
Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,1/24,0.06286201570363556,0.09909372504290676,0,0,16.343724364232976,45.22003200693963,FOXO3
Glycogen Metabolism R-HSA-8982491,1/24,0.06286201570363556,0.09909372504290676,0,0,16.343724364232976,45.22003200693963,GYS2
Interleukin-1 Family Signaling R-HSA-446652,2/152,0.06352624274635385,0.09985303098349298,0,0,5.075897435897436,13.990707202843971,MAP2K1;TP53
Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,1/25,0.06539532289924611,0.10162284552808984,0,0,15.66194968553459,42.71490645721221,CAMK2G
Deadenylation Of mRNA R-HSA-429947,1/25,0.06539532289924611,0.10162284552808984,0,0,15.66194968553459,42.71490645721221,EIF4E
Signaling By ERBB2 In Cancer R-HSA-1227990,1/25,0.06539532289924611,0.10162284552808984,0,0,15.66194968553459,42.71490645721221,ERBB2
Interleukin-7 Signaling R-HSA-1266695,1/25,0.06539532289924611,0.10162284552808984,0,0,15.66194968553459,42.71490645721221,H3C13
DNA Replication R-HSA-69306,2/155,0.06573379992087668,0.10185945766776074,0,0,4.975615887380593,13.544333118835452,H3C13;H2BC3
APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,1/26,0.0679219085557706,0.10436315724720932,0,0,15.034716981132076,40.43431729208938,NEK2
Pyroptosis R-HSA-5620971,1/26,0.0679219085557706,0.10436315724720932,0,0,15.034716981132076,40.43431729208938,TP53
HDMs Demethylate Histones R-HSA-3214842,1/26,0.0679219085557706,0.10436315724720932,0,0,15.034716981132076,40.43431729208938,H3C13
RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,1/27,0.0704417901623858,0.10763033301347776,0,0,14.455732946298983,38.35060533159885,CDK7
VEGFR2 Mediated Vascular Permeability R-HSA-5218920,1/27,0.0704417901623858,0.10763033301347776,0,0,14.455732946298983,38.35060533159885,MTOR
Recycling Pathway Of L1 R-HSA-437239,1/28,0.07295498516431843,0.1108510469024505,0,0,13.919636617749823,36.44039305811433,RPS6KA1
MET Promotes Cell Motility R-HSA-8875878,1/28,0.07295498516431843,0.1108510469024505,0,0,13.919636617749823,36.44039305811433,RAP1B
Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,TP53
Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,PPP2CB
SUMOylation Of Intracellular Receptors R-HSA-4090294,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,ESR1
Downregulation Of ERBB2 Signaling R-HSA-8863795,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,ERBB2
Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,MTOR
"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,FOXO3
TNFs Bind Their Physiological Receptors R-HSA-5669034,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,CD27
Uptake And Actions Of Bacterial Toxins R-HSA-5339562,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,MAP2K1
mRNA Capping R-HSA-72086,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,CDK7
Negative Regulation Of FGFR3 Signaling R-HSA-5654732,1/29,0.07546151096326235,0.11144831859413028,0,0,13.421832884097036,34.683795119411634,PPP2CB
SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,2/168,0.07558926178870627,0.11144831859413028,0,0,4.582947173308619,11.835190890705748,TP53;ESR1
Separation Of Sister Chromatids R-HSA-2467813,2/170,0.07714545836369978,0.11343700463694564,0,0,4.527930402930403,11.600841002731354,PPP2CB;CENPA
RNA Polymerase I Transcription Termination R-HSA-73863,1/30,0.07796138492038997,0.11432943043285072,0,0,12.958360442420298,33.06379625497651,CDK7
SUMOylation R-HSA-2990846,2/174,0.0802883718469711,0.1161178879269828,0,0,4.421735241502684,11.152193215564584,TP53;ESR1
RUNX2 Regulates Bone Development R-HSA-8941326,1/31,0.08045462435891494,0.1161178879269828,0,0,12.525786163522012,31.56575680442027,RB1
Regulation Of MECP2 Expression And Activity R-HSA-9022692,1/31,0.08045462435891494,0.1161178879269828,0,0,12.525786163522012,31.56575680442027,CAMK2G
Diseases Associated With TLR Signaling Cascade R-HSA-5602358,1/31,0.08045462435891494,0.1161178879269828,0,0,12.525786163522012,31.56575680442027,FGA
"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",1/31,0.08045462435891494,0.1161178879269828,0,0,12.525786163522012,31.56575680442027,CAMK2G
Negative Regulation Of FGFR4 Signaling R-HSA-5654733,1/31,0.08045462435891494,0.1161178879269828,0,0,12.525786163522012,31.56575680442027,PPP2CB
Phase 0 - Rapid Depolarisation R-HSA-5576892,1/32,0.08294124653654229,0.118456558369422,0,0,12.121119902617163,30.177016409267804,CAMK2G
Generation Of Second Messenger Molecules R-HSA-202433,1/32,0.08294124653654229,0.118456558369422,0,0,12.121119902617163,30.177016409267804,VASP
Glucagon Signaling In Metabolic Regulation R-HSA-163359,1/32,0.08294124653654229,0.118456558369422,0,0,12.121119902617163,30.177016409267804,PRKACG
Nuclear Signaling By ERBB4 R-HSA-1251985,1/32,0.08294124653654229,0.118456558369422,0,0,12.121119902617163,30.177016409267804,ESR1
Apoptosis R-HSA-109581,2/178,0.0834709812875242,0.1189026738653014,0,0,4.3203671328671325,10.728578628901712,BAD;TP53
Packaging Of Telomere Ends R-HSA-171306,1/33,0.08542126868690271,0.11980880505573276,0,0,11.741745283018869,28.88657396987172,H2BC3
Diseases Of Carbohydrate Metabolism R-HSA-5663084,1/33,0.08542126868690271,0.11980880505573276,0,0,11.741745283018869,28.88657396987172,GYS2
Signaling By WNT In Cancer R-HSA-4791275,1/33,0.08542126868690271,0.11980880505573276,0,0,11.741745283018869,28.88657396987172,PPP2CB
Signaling To ERKs R-HSA-187687,1/33,0.08542126868690271,0.11980880505573276,0,0,11.741745283018869,28.88657396987172,MAP2K1
Formation Of Early Elongation Complex R-HSA-113418,1/33,0.08542126868690271,0.11980880505573276,0,0,11.741745283018869,28.88657396987172,CDK7
Negative Regulation Of FGFR1 Signaling R-HSA-5654726,1/33,0.08542126868690271,0.11980880505573276,0,0,11.741745283018869,28.88657396987172,PPP2CB
CD28 Co-Stimulation R-HSA-389356,1/34,0.08789470799411693,0.12264899304281111,0,0,11.385363064608349,27.684827361193253,MTOR
Negative Regulation Of FGFR2 Signaling R-HSA-5654727,1/34,0.08789470799411693,0.12264899304281111,0,0,11.385363064608349,27.684827361193253,PPP2CB
Cilium Assembly R-HSA-5617833,2/186,0.08995058913628466,0.12481763921537196,0,0,4.1308528428093645,9.949137463455036,CDK1;NEK2
RHOBTB GTPase Cycle R-HSA-9706574,1/35,0.09036158158919066,0.12481763921537196,0,0,11.049944506104328,26.563360328124432,PDE5A
Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,1/35,0.09036158158919066,0.12481763921537196,0,0,11.049944506104328,26.563360328124432,RAP1B
Transport Of SLBP Independent Mature mRNA R-HSA-159227,1/35,0.09036158158919066,0.12481763921537196,0,0,11.049944506104328,26.563360328124432,EIF4E
Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,1/36,0.09282190658441714,0.12725208747287262,0,0,10.733692722371968,25.514766917792368,RB1
Transport Of SLBP Dependant Mature mRNA R-HSA-159230,1/36,0.09282190658441714,0.12725208747287262,0,0,10.733692722371968,25.514766917792368,EIF4E
Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,1/36,0.09282190658441714,0.12725208747287262,0,0,10.733692722371968,25.514766917792368,CDK1
Cleavage Of Damaged Purine R-HSA-110331,1/37,0.0952757000126654,0.12899952452209892,0,0,10.435010482180294,24.53250600399325,H2BC3
Early SARS-CoV-2 Infection Events R-HSA-9772572,1/37,0.0952757000126654,0.12899952452209892,0,0,10.435010482180294,24.53250600399325,RB1
FLT3 Signaling R-HSA-9607240,1/37,0.0952757000126654,0.12899952452209892,0,0,10.435010482180294,24.53250600399325,FOXO3
Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,1/37,0.0952757000126654,0.12899952452209892,0,0,10.435010482180294,24.53250600399325,FGA
Triglyceride Metabolism R-HSA-8979227,1/37,0.0952757000126654,0.12899952452209892,0,0,10.435010482180294,24.53250600399325,PRKACG
Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,1/38,0.09772297891050057,0.13133776281091844,0,0,10.152473227944926,23.610780056259,TP53
Diseases Of Mitotic Cell Cycle R-HSA-9675126,1/38,0.09772297891050057,0.13133776281091844,0,0,10.152473227944926,23.610780056259,RB1
FCGR3A-mediated IL10 Synthesis R-HSA-9664323,1/38,0.09772297891050057,0.13133776281091844,0,0,10.152473227944926,23.610780056259,PRKACG
Signaling By FGFR3 R-HSA-5654741,1/39,0.10016376022168876,0.13395984557766197,0,0,9.88480635551142,22.74443362032508,PPP2CB
Transcriptional Regulation By VENTX R-HSA-8853884,1/39,0.10016376022168876,0.13395984557766197,0,0,9.88480635551142,22.74443362032508,TP53
Interferon Signaling R-HSA-913531,2/200,0.1016331727713355,0.1355935256241964,0,0,3.836052836052836,8.77069478933889,CAMK2G;EIF4E
RET Signaling R-HSA-8853659,1/40,0.10259806088452916,0.13621635753358605,0,0,9.630865989356556,21.928867853316252,PRKACG
Signaling By FGFR4 R-HSA-5654743,1/40,0.10259806088452916,0.13621635753358605,0,0,9.630865989356556,21.928867853316252,PPP2CB
Cleavage Of Damaged Pyrimidine R-HSA-110329,1/42,0.10744728772228491,0.1412828518848314,0,0,9.160147261849977,20.434043374832477,H2BC3
Formation Of Incision Complex In GG-NER R-HSA-5696395,1/42,0.10744728772228491,0.1412828518848314,0,0,9.160147261849977,20.434043374832477,CDK7
Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,1/42,0.10744728772228491,0.1412828518848314,0,0,9.160147261849977,20.434043374832477,EIF4E
Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,1/42,0.10744728772228491,0.1412828518848314,0,0,9.160147261849977,20.434043374832477,PRKACG
Programmed Cell Death R-HSA-5357801,2/208,0.10849000422181644,0.14231182807993667,0,0,3.685586258401792,8.186045456121757,BAD;TP53
Signaling By ROBO Receptors R-HSA-376176,2/209,0.1093557955008174,0.14274263515331026,0,0,3.66759568933482,8.116934022105527,VASP;PRKACG
Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,1/43,0.10986224753115834,0.14274263515331026,0,0,8.941599281221922,19.747772315999956,CDK7
GPER1 Signaling R-HSA-9634597,1/43,0.10986224753115834,0.14274263515331026,0,0,8.941599281221922,19.747772315999956,PRKACG
Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,1/43,0.10986224753115834,0.14274263515331026,0,0,8.941599281221922,19.747772315999956,EIF4E
"Base-Excision Repair, AP Site Formation R-HSA-73929",1/44,0.11227079396310412,0.14483991579674044,0,0,8.733216322948662,19.098160081121275,H2BC3
TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,1/44,0.11227079396310412,0.14483991579674044,0,0,8.733216322948662,19.098160081121275,TP53
Interleukin-12 Signaling R-HSA-9020591,1/44,0.11227079396310412,0.14483991579674044,0,0,8.733216322948662,19.098160081121275,RAP1B
Regulation Of Complement Cascade R-HSA-977606,1/45,0.1146729436907043,0.14689953208153456,0,0,8.534305317324185,18.482498984150983,C1R
Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,1/45,0.1146729436907043,0.14689953208153456,0,0,8.534305317324185,18.482498984150983,CDK7
TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,1/45,0.1146729436907043,0.14689953208153456,0,0,8.534305317324185,18.482498984150983,TP53
RNA Polymerase I Transcription Initiation R-HSA-73762,1/46,0.11706871342498994,0.1492694318029592,0,0,8.344234800838574,17.89833543767599,CDK7
HIV Transcription Initiation R-HSA-167161,1/46,0.11706871342498994,0.1492694318029592,0,0,8.344234800838574,17.89833543767599,CDK7
PKMTs Methylate Histone Lysines R-HSA-3214841,1/47,0.11945811977341562,0.1519618407350194,0,0,8.162428219852337,17.34344121433972,H3C13
Inhibition Of DNA Recombination At Telomere R-HSA-9670095,1/48,0.1218411792961756,0.1546337008700883,0,0,7.988358089120835,16.815788479202197,H2BC3
RMTs Methylate Histone Arginines R-HSA-3214858,1/49,0.12421790857292912,0.15656035942256272,0,0,7.821540880503145,16.313528042717785,H3C13
Signaling By ERBB2 R-HSA-1227986,1/49,0.12421790857292912,0.15656035942256272,0,0,7.821540880503145,16.313528042717785,ERBB2
Signaling By FGFR1 R-HSA-5654736,1/49,0.12421790857292912,0.15656035942256272,0,0,7.821540880503145,16.313528042717785,PPP2CB
Aquaporin-mediated Transport R-HSA-445717,1/50,0.1265883240687765,0.15881608547160722,0,0,7.661532537543319,15.834970375184442,PRKACG
Ion Homeostasis R-HSA-5578775,1/50,0.1265883240687765,0.15881608547160722,0,0,7.661532537543319,15.834970375184442,CAMK2G
Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,1/51,0.1289524422762036,0.1606765055241079,0,0,7.507924528301887,15.378568956697888,TP53
Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,1/51,0.1289524422762036,0.1606765055241079,0,0,7.507924528301887,15.378568956697888,CDC25A
Nonhomologous End-Joining (NHEJ) R-HSA-5693571,1/51,0.1289524422762036,0.1606765055241079,0,0,7.507924528301887,15.378568956697888,H2BC3
SARS-CoV-1 Infection R-HSA-9678108,1/52,0.1313102795600359,0.16250389800755577,0,0,7.360340362560119,14.942905667794824,RB1
Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,1/52,0.1313102795600359,0.16250389800755577,0,0,7.360340362560119,14.942905667794824,ERBB2
Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,1/52,0.1313102795600359,0.16250389800755577,0,0,7.360340362560119,14.942905667794824,CDK7
Metabolism Of Proteins R-HSA-392499,8/1890,0.13360252601173095,0.1642989510466621,0,0,1.6692695097722128,3.360049411377201,FGA;H3C13;H2BC3;CDK1;TP53;EIF4E;ESR1;CDC25A
Ion Transport By P-type ATPases R-HSA-936837,1/53,0.13366185231401212,0.1642989510466621,0,0,7.218432510885341,14.526677903865671,CAMK2G
Nuclear Envelope Breakdown R-HSA-2980766,1/53,0.13366185231401212,0.1642989510466621,0,0,7.218432510885341,14.526677903865671,CDK1
Chromatin Modifying Enzymes R-HSA-3247509,2/238,0.13521720210123722,0.16583813800308692,0,0,3.212190352020861,6.427184589634703,H3C13;H2BC3
Interleukin-12 Family Signaling R-HSA-447115,1/54,0.13600717688085265,0.16643383837545056,0,0,7.081879672481311,14.128687210183031,RAP1B
Amino Acids Regulate mTORC1 R-HSA-9639288,1/55,0.13834626953351245,0.16854211455419,0,0,6.950384346610762,13.747829218668,MTOR
Complement Cascade R-HSA-166658,1/55,0.13834626953351245,0.16854211455419,0,0,6.950384346610762,13.747829218668,C1R
Deadenylation-dependent mRNA Decay R-HSA-429914,1/56,0.14067914651365568,0.1702466662455081,0,0,6.823670668953688,13.383084716807277,EIF4E
E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,1/56,0.14067914651365568,0.1702466662455081,0,0,6.823670668953688,13.383084716807277,H2BC3
Stabilization Of P53 R-HSA-69541,1/56,0.14067914651365568,0.1702466662455081,0,0,6.823670668953688,13.383084716807277,TP53
Regulated Necrosis R-HSA-5218859,1/57,0.1430058240466105,0.17116889661596485,0,0,6.701482479784366,13.033511707426957,TP53
Ribosomal Scanning And Start Codon Recognition R-HSA-72702,1/57,0.1430058240466105,0.17116889661596485,0,0,6.701482479784366,13.033511707426957,EIF4E
Signaling By ERBB4 R-HSA-1236394,1/57,0.1430058240466105,0.17116889661596485,0,0,6.701482479784366,13.033511707426957,ESR1
Translation Initiation Complex Formation R-HSA-72649,1/57,0.1430058240466105,0.17116889661596485,0,0,6.701482479784366,13.033511707426957,EIF4E
NRAGE Signals Death Thru JNK R-HSA-193648,1/57,0.1430058240466105,0.17116889661596485,0,0,6.701482479784366,13.033511707426957,BAD
"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",1/58,0.14532631826774292,0.17318844464587227,0,0,6.583581595498179,12.698238337093317,EIF4E
Formation Of RNA Pol II Elongation Complex R-HSA-112382,1/58,0.14532631826774292,0.17318844464587227,0,0,6.583581595498179,12.698238337093317,CDK7
Degradation Of GLI1 By Proteasome R-HSA-5610780,1/59,0.14764064534934584,0.17480396754565403,0,0,6.469746258945999,12.376456572299608,PRKACG
Degradation Of GLI2 By Proteasome R-HSA-5610783,1/59,0.14764064534934584,0.17480396754565403,0,0,6.469746258945999,12.376456572299608,PRKACG
GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,1/59,0.14764064534934584,0.17480396754565403,0,0,6.469746258945999,12.376456572299608,PRKACG
Transcriptional Regulation By MECP2 R-HSA-8986944,1/60,0.14994882131606077,0.17648409189928757,0,0,6.359769747361688,12.067416554890574,CAMK2G
Meiotic Synapsis R-HSA-1221632,1/60,0.14994882131606077,0.17648409189928757,0,0,6.359769747361688,12.067416554890574,H2BC3
"Platelet Activation, Signaling And Aggregation R-HSA-76002",2/254,0.15002761011548213,0.17648409189928757,0,0,3.005799755799756,5.701809568350228,RAP1B;FGA
Signaling By MET R-HSA-6806834,1/63,0.15683660288249493,0.18409790080842217,0,0,6.051125989044431,11.21001805928369,RAP1B
Semaphorin Interactions R-HSA-373755,1/64,0.1591203344708972,0.18598039093072816,0,0,5.954776879305181,10.945442883265992,ERBB2
Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,1/64,0.1591203344708972,0.18598039093072816,0,0,5.954776879305181,10.945442883265992,CDK7
Dual Incision In TC-NER R-HSA-6782135,1/65,0.16139799477052716,0.18783979391378372,0,0,5.861438679245283,10.690572191682948,CDK7
p53-Dependent G1 DNA Damage Response R-HSA-69563,1/65,0.16139799477052716,0.18783979391378372,0,0,5.861438679245283,10.690572191682948,TP53
Integrin Cell Surface Interactions R-HSA-216083,1/66,0.16366959960719915,0.19007913160326528,0,0,5.770972423802612,10.444914844508016,FGA
Post-translational Protein Modification R-HSA-597592,6/1383,0.1678294383733449,0.19449725167419415,0,0,1.685639070442992,3.0085405187128837,FGA;H2BC3;CDK1;TP53;ESR1;CDC25A
Organelle Biogenesis And Maintenance R-HSA-1852241,2/275,0.16993407432578164,0.1965199548756925,0,0,2.7716258100873485,4.912276357099597,CDK1;NEK2
Transcription Of HIV Genome R-HSA-167172,1/69,0.17044823907414808,0.1966987062733312,0,0,5.5155382907880135,9.75877212797992,CDK7
"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",1/71,0.17493734325009064,0.20145416159536755,0,0,5.3574123989218325,9.339723869609994,PRKACG
Base Excision Repair R-HSA-73884,1/72,0.1771729455832538,0.20232484600008321,0,0,5.28169014084507,9.140645755790116,H2BC3
Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,1/72,0.1771729455832538,0.20232484600008321,0,0,5.28169014084507,9.140645755790116,CDK1
Regulation Of RUNX2 Expression And Activity R-HSA-8939902,1/72,0.1771729455832538,0.20232484600008321,0,0,5.28169014084507,9.140645755790116,ESR1
Signaling By FGFR2 R-HSA-5654738,1/72,0.1771729455832538,0.20232484600008321,0,0,5.28169014084507,9.140645755790116,PPP2CB
APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,1/73,0.1794026022045267,0.20444421542890856,0,0,5.208071278825996,8.948106135360762,RB1
RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,1/74,0.18162632858411695,0.20611950567533607,0,0,5.136469371930732,8.761809189641154,CDK7
"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",1/74,0.18162632858411695,0.20611950567533607,0,0,5.136469371930732,8.761809189641154,BAD
ISG15 Antiviral Mechanism R-HSA-1169408,1/75,0.18384414020581769,0.20777426589376505,0,0,5.066802651708312,8.581476165166299,EIF4E
Nuclear Envelope (NE) Reassembly R-HSA-2995410,1/75,0.18384414020581769,0.20777426589376505,0,0,5.066802651708312,8.581476165166299,CDK1
Protein Ubiquitination R-HSA-8852135,1/76,0.1860560525481816,0.2098405376161966,0,0,4.998993710691824,8.406844180342443,H2BC3
Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,1/77,0.1882620809769539,0.21189168373332057,0,0,4.932969215491559,8.237665132225366,CDK7
Processing Of DNA Double-Strand Break Ends R-HSA-5693607,1/80,0.19484501606792143,0.21795546787147865,0,0,4.744924767136374,7.760565621373132,H2BC3
RNA Polymerase II Pre-transcription Events R-HSA-674695,1/80,0.19484501606792143,0.21795546787147865,0,0,4.744924767136374,7.760565621373132,CDK7
Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,1/80,0.19484501606792143,0.21795546787147865,0,0,4.744924767136374,7.760565621373132,CDK1
Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,1/82,0.19920450038996365,0.22237726880267367,0,0,4.627300256231074,7.465794242771092,CDK7
Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,1/83,0.2013755464220889,0.22388704043268828,0,0,4.570639668660838,7.3248327414165475,EIF4E
Transport Of Mature Transcript To Cytoplasm R-HSA-72202,1/83,0.2013755464220889,0.22388704043268828,0,0,4.570639668660838,7.3248327414165475,EIF4E
Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,1/84,0.20354081521299808,0.22583534669677477,0,0,4.51534439645374,7.187925847991766,PPP2CB
Cell Junction Organization R-HSA-446728,1/86,0.20785408138648875,0.22968925761294817,0,0,4.40865704772475,6.92564302052444,VASP
Signaling By FGFR R-HSA-190236,1/86,0.20785408138648875,0.22968925761294817,0,0,4.40865704772475,6.92564302052444,PPP2CB
ER-Phagosome Pathway R-HSA-1236974,1/89,0.2142810272062562,0.23583847461131213,0,0,4.257718696397942,6.55887478187328,FGA
Interferon Gamma Signaling R-HSA-877300,1/89,0.2142810272062562,0.23583847461131213,0,0,4.257718696397942,6.55887478187328,CAMK2G
Chaperonin-mediated Protein Folding R-HSA-390466,1/90,0.21641194796983468,0.2372291293376745,0,0,4.209667161331355,6.443196670460662,TP53
Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,1/90,0.21641194796983468,0.2372291293376745,0,0,4.209667161331355,6.443196670460662,TP53
Telomere Maintenance R-HSA-157579,1/92,0.22065678694231972,0.24139852491489783,0,0,4.116732324279494,6.2209868160475805,H2BC3
P75 NTR Receptor-Mediated Signaling R-HSA-193704,1/95,0.2269817606631972,0.2478224013628121,0,0,3.9847450822962656,5.908921158911916,BAD
Protein Folding R-HSA-391251,1/96,0.2290788681344704,0.24961382643337707,0,0,3.942601787487587,5.810168619029014,TP53
Hedgehog Off State R-HSA-5610787,1/98,0.23325634531533676,0.2536604789015689,0,0,3.8609219996109703,5.6200246083287,PRKACG
TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,1/100,0.23741160244685375,0.2576669574175179,0,0,3.7825424051839143,5.43914439332398,CD27
Antigen processing-Cross Presentation R-HSA-1236975,1/104,0.2456559199877992,0.2660867093729231,0,0,3.634914819564023,5.102778558422387,FGA
Post-translational Protein Phosphorylation R-HSA-8957275,1/106,0.24974521057517932,0.2699814825783065,0,0,3.565318957771788,4.946217041895164,FGA
Nucleotide Excision Repair R-HSA-5696398,1/108,0.25381274145450977,0.2732983653063324,0,0,3.498324810439076,4.796757877346515,CDK7
L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,1/108,0.25381274145450977,0.2732983653063324,0,0,3.498324810439076,4.796757877346515,EIF4E
GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,1/109,0.25583838254966373,0.27493830108971723,0,0,3.46575821104123,4.724554005177176,EIF4E
HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,1/114,0.26588590923208694,0.28461759755372124,0,0,3.3115712138921354,4.38679856497224,H2BC3
Macroautophagy R-HSA-1632852,1/114,0.26588590923208694,0.28461759755372124,0,0,3.3115712138921354,4.38679856497224,MTOR
Cap-dependent Translation Initiation R-HSA-72737,1/116,0.2698675316639436,0.28775348892822056,0,0,3.2536505332239543,4.261709763761167,EIF4E
TCR Signaling R-HSA-202403,1/116,0.2698675316639436,0.28775348892822056,0,0,3.2536505332239543,4.261709763761167,VASP
Homology Directed Repair R-HSA-5693538,1/119,0.27580025484775794,0.29350727510062963,0,0,3.170450911416693,4.08378930425916,H2BC3
Cell-Cell Communication R-HSA-1500931,1/120,0.2777672950864116,0.295026622159742,0,0,3.143649912795307,4.026926207904397,VASP
Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,1/123,0.2836370059612168,0.30067721368369305,0,0,3.065883080729972,3.86319665424253,FGA
Platelet Degranulation R-HSA-114608,1/125,0.28752410838833287,0.3042082926275011,0,0,3.0161290322580645,3.759449710134971,FGA
Cardiac Conduction R-HSA-5576891,1/126,0.2894598889698799,0.3056651723291975,0,0,2.991849056603773,3.709110594347332,CAMK2G
Autophagy R-HSA-9612973,1/128,0.29331597663197484,0.3091403453134687,0,0,2.944436190759174,3.611365216958303,MTOR
Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,1/130,0.2971515228201141,0.3122571201848047,0,0,2.898493491297353,3.517359800013655,FGA
Transport Of Small Molecules R-HSA-382551,3/706,0.29741491703159645,0.3122571201848047,0,0,1.610158145761861,1.952521383629655,PRKACG;CAMK2G;ADD2
ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,1/131,0.29906162642283773,0.3133845012515177,0,0,2.8760522496371554,3.471698829323926,PRKACG
Signaling By Hedgehog R-HSA-5358351,1/135,0.3066512225913464,0.3207231716203948,0,0,2.7896367220501266,3.297474074758064,PRKACG
Late Phase Of HIV Life Cycle R-HSA-162599,1/136,0.3085359835030053,0.3220785934659235,0,0,2.768832983927324,3.2559172283809583,CDK7
Death Receptor Signaling R-HSA-73887,1/139,0.31416014594522135,0.32722233728439126,0,0,2.7082307902652447,3.135731531516588,BAD
Metabolism R-HSA-1430728,7/2049,0.31465987095354625,0.32722233728439126,0,0,1.3058536687019402,1.5099102782933207,GYS2;BCKDK;PPP2CB;PFKL;MARCKS;KCNB1;PRKACG
C-type Lectin Receptors (CLRs) R-HSA-5621481,1/141,0.3178846185875369,0.3299485509817508,0,0,2.6692722371967657,3.0591642823316247,PRKACG
HIV Life Cycle R-HSA-162587,1/149,0.33258501155690634,0.3445530328061132,0,0,2.523967363590005,2.7785341508286368,CDK7
Cellular Response To Starvation R-HSA-9711097,1/153,0.3398181503324097,0.3507179777959022,0,0,2.4570506454816288,2.6520044847533275,MTOR
G Alpha (S) Signaling Events R-HSA-418555,1/153,0.3398181503324097,0.3507179777959022,0,0,2.4570506454816288,2.6520044847533275,PRKACG
Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,1/165,0.3610590516999416,0.3716432396031072,0,0,2.275885872066268,2.3184762447563068,PRKACG
Neutrophil Degranulation R-HSA-6798695,2/468,0.3614519259028392,0.3716432396031072,0,0,1.6077913502806207,1.6361306524722594,RAP1B;PFKL
Ion Channel Transport R-HSA-983712,1/175,0.37824622120999735,0.3881813939997534,0,0,2.144003469963132,2.08442143462703,CAMK2G
Peptide Ligand-Binding Receptors R-HSA-375276,1/196,0.4128755746659732,0.42292685270091257,0,0,1.9110788582486693,1.6905575642291697,ANXA1
HIV Infection R-HSA-162906,1/229,0.4635039241500508,0.47390027385061273,0,0,1.6317444554783185,1.2547142794418786,CDK7
Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,1/242,0.4822495402261153,0.49214645243224825,0,0,1.54270727315431,1.125086511040914,EIF4E
Diseases Of Metabolism R-HSA-5668914,1/247,0.48928690585684737,0.49747200279497306,0,0,1.510967939868078,1.080049314904101,GYS2
Leishmania Infection R-HSA-9658195,1/247,0.48928690585684737,0.49747200279497306,0,0,1.510967939868078,1.080049314904101,PRKACG
Translation R-HSA-72766,1/281,0.5347126979809235,0.5426490645557795,0,0,1.3252021563342318,0.8296105935785553,EIF4E
SARS-CoV-2 Infection R-HSA-9694516,1/283,0.5372576223710036,0.5442220730313685,0,0,1.3156697444132208,0.817396083056755,RB1
Metabolism Of RNA R-HSA-8953854,2/666,0.5409660296076013,0.5469656528564841,0,0,1.116890639481001,0.6862162618823503,CDK7;EIF4E
Extracellular Matrix Organization R-HSA-1474244,1/291,0.5473014048266289,0.552350310775214,0,0,1.2788549121665582,0.7708369778056472,FGA
Metabolism Of Amino Acids And Derivatives R-HSA-71291,1/364,0.6296030478202124,0.6342410076568253,0,0,1.0178803472113935,0.4709383650992488,BCKDK
SARS-CoV Infections R-HSA-9679506,1/369,0.63466866032457,0.638168671319007,0,0,1.0037940935192782,0.4563772040435828,RB1
Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,1/378,0.6436159731339626,0.6459778666133532,0,0,0.9793804113908212,0.4315669612308445,FGA
RHO GTPase Cycle R-HSA-9012999,1/441,0.7004987739087187,0.7017817386960973,0,0,0.8364493996569469,0.29774475619771057,PDE5A
Metabolism Of Lipids R-HSA-556833,1/732,0.8668380284213164,0.8668380284213164,0,0,0.49596056061740185,0.07087432047821886,PRKACG
